Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)
  7. Department of Pathology and Laboratory Medicine (415)
  8. Gastrointestinal Oncology Service (386)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in ER+/ HER2-metastatic breast cancer (mBC): Biomarker analyses from a phase I/II study
    Meeting Abstract

    Chandarlapaty, S.; Bardia, A.; Lord, S.; Linden, H.; Pelekanou, V.; Ternes, N.; Ming, J.; Boutet, V.; Boitier, E.; Gosselin, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Artificial intelligence analysis of advanced breast cancer patients from a phase I trial of trastuzumab deruxtecan (T-DxD): HER2 and histopathology features as predictors of clinical benefit
    Meeting Abstract

    Modi, S.; Glass, B.; Prakash, A.; Taylor-Weiner, A.; Elliott, H.; Wapinski, I.; Sugihara, M.; Saito, K.; Kerner, J. K.; Phillips, R.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: Role for onco-anaesthesia
    Research Letter

    Silagy, A. W.; Hannum, M. L.; Mano, R.; Attalla, K.; Scarpa, J. R.; DiNatale, R. G.; Marcon, J.; Coleman, J. A.; Russo, P.; Tan, K. S.; more...
    British Journal of Anaesthesia (2020)

    Fulltext@MSK | Save
  • TBCRC 030: A phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: Evaluating the homologous recombination deficiency (HRD) biomarker
    Journal Article

    Mayer, E. L.; Abramson, V.; Jankowitz, R.; Falkson, C.; Marcom, P. K.; Traina, T.; Carey, L.; Rimawi, M.; Specht, J.; Miller, K.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group
    Review

    Mosele, F.; Remon, J.; Mateo, J.; Westphalen, C. B.; Barlesi, F.; Lolkema, M. P.; Normanno, N.; Scarpa, A.; Robson, M.; Meric-Bernstam, F.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Replisome bypass of transcription complexes and R-loops
    Journal Article

    Brüning, J. G.; Marians, K. J.
    Nucleic Acids Research (2020)

    Fulltext@MSK | Save
  • Lifetime benefits and harms of prostate-specific antigen-based risk-stratified screening for prostate cancer
    Journal Article

    Heijnsdijk, E. A. M.; Gulati, R.; Tsodikov, A.; Lange, J. M.; Mariotto, A. B.; Vickers, A. J.; Carlsson, S. V.; Etzioni, R.
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: Expert recommendations from the World Sarcoma Network
    Review

    Demetri, G. D.; Antonescu, C. R.; Bjerkehagen, B.; Bovée, J. V. M. G.; Boye, K.; Chacón, M.; Dei Tos, A. P.; Desai, J.; Fletcher, J. A.; Gelderblom, H.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Regulating inspiratory pressure to individualise tidal volumes in a simulated two-patient, one-ventilator system
    Correspondence

    Chen, G. H.; Hellman, S.; Irie, T.; Downey, R. J.; Fischer, G. W.
    British Journal of Anaesthesia (2020)

    Fulltext@MSK | Save
  • Resting-state functional connectivity in early postanaesthesia recovery is characterised by globally reduced anticorrelations
    Journal Article

    Nir, T.; Jacob, Y.; Huang, K. H.; Schwartz, A. E.; Brallier, J. W.; Ahn, H.; Kundu, P.; Tang, C. Y.; Delman, B. N.; McCormick, P. J.; more...
    British Journal of Anaesthesia (2020)

    Fulltext@MSK | Save